PT2348022E - Processo para a produção de 1-(3-(2-(1- benzotiofen-5-il)etoxi)propil)azetidin-3-ol ou dos seus sais - Google Patents

Processo para a produção de 1-(3-(2-(1- benzotiofen-5-il)etoxi)propil)azetidin-3-ol ou dos seus sais

Info

Publication number
PT2348022E
PT2348022E PT110022654T PT11002265T PT2348022E PT 2348022 E PT2348022 E PT 2348022E PT 110022654 T PT110022654 T PT 110022654T PT 11002265 T PT11002265 T PT 11002265T PT 2348022 E PT2348022 E PT 2348022E
Authority
PT
Portugal
Prior art keywords
benzothiophen
azetidin
ethoxy
propyl
salts
Prior art date
Application number
PT110022654T
Other languages
English (en)
Inventor
Kenji Yonezawa
Akihito Saitoh
Yoshiaki Suzuki
Mitsuhide Kawamura
Takashi Nakai
Takahiko Kusanagi
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PT2348022E publication Critical patent/PT2348022E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT110022654T 2005-03-28 2006-03-27 Processo para a produção de 1-(3-(2-(1- benzotiofen-5-il)etoxi)propil)azetidin-3-ol ou dos seus sais PT2348022E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005090831 2005-03-28
JP2005174738 2005-06-15
JP2005206808 2005-07-15
JP2005230666 2005-08-09

Publications (1)

Publication Number Publication Date
PT2348022E true PT2348022E (pt) 2013-02-13

Family

ID=37053344

Family Applications (3)

Application Number Title Priority Date Filing Date
PT10007872T PT2248809E (pt) 2005-03-28 2006-03-27 (3-[2-(benzo[b]tiofen-5-il)-etoxi]-propanoatos de alquilo a título de intermediários na produção de derivados de azetidin-3-ol
PT10002020T PT2210884E (pt) 2005-03-28 2006-03-27 Processo para a produção de ácido 1-(3-(2-(1- benzotiofen-5-il)etoxi)propiónico e de 1-(3-(2-(1- benzotiofen-5-il)etoxi)propil)azetidin-3-ol bem como dos seus sais
PT110022654T PT2348022E (pt) 2005-03-28 2006-03-27 Processo para a produção de 1-(3-(2-(1- benzotiofen-5-il)etoxi)propil)azetidin-3-ol ou dos seus sais

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT10007872T PT2248809E (pt) 2005-03-28 2006-03-27 (3-[2-(benzo[b]tiofen-5-il)-etoxi]-propanoatos de alquilo a título de intermediários na produção de derivados de azetidin-3-ol
PT10002020T PT2210884E (pt) 2005-03-28 2006-03-27 Processo para a produção de ácido 1-(3-(2-(1- benzotiofen-5-il)etoxi)propiónico e de 1-(3-(2-(1- benzotiofen-5-il)etoxi)propil)azetidin-3-ol bem como dos seus sais

Country Status (22)

Country Link
US (2) US7951963B2 (pt)
EP (4) EP2348022B1 (pt)
JP (1) JP5031554B2 (pt)
KR (2) KR101337382B1 (pt)
CN (1) CN101151257B (pt)
AT (2) ATE546443T1 (pt)
AU (1) AU2006229271B2 (pt)
BR (1) BRPI0609496C8 (pt)
CA (2) CA2600381C (pt)
CY (3) CY1112956T1 (pt)
DK (2) DK2248809T3 (pt)
ES (3) ES2398934T3 (pt)
IL (2) IL186044A (pt)
MX (1) MX2007011938A (pt)
NO (3) NO340071B1 (pt)
NZ (2) NZ583580A (pt)
PL (3) PL2348022T3 (pt)
PT (3) PT2248809E (pt)
SG (1) SG155251A1 (pt)
SI (3) SI2210884T1 (pt)
WO (1) WO2006104088A1 (pt)
ZA (1) ZA200708262B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100956990B1 (ko) 2001-10-19 2010-05-11 토야마 케미칼 컴퍼니 리미티드 알킬에테르유도체 또는 그 염
ES2398934T3 (es) * 2005-03-28 2013-03-22 Toyama Chemical Co., Ltd. Proceso de la producción de1-(3-(2-(1-benzotiofen-5-il)etoxi)propil)acetidin-ol o sales del mismo
JP4902247B2 (ja) * 2005-04-08 2012-03-21 富山化学工業株式会社 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
DK3091011T3 (en) 2006-04-07 2018-02-26 Vertex Pharma MODULATORS OF ATP BINDING CASSETTE TRANSPORT
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
AU2007279673B2 (en) * 2006-08-04 2012-04-19 Toyama Chemical Co., Ltd. Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
JP5592205B2 (ja) * 2009-09-03 2014-09-17 富山化学工業株式会社 (1−ベンゾチオフェン−5−イル)酢酸またはその塩の製造法
JP5763313B2 (ja) * 2009-09-03 2015-08-12 富山化学工業株式会社 2−(1−ベンゾチオフェン−5−イル)エタノールの製造法
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
SG184987A1 (en) * 2010-04-22 2012-11-29 Vertex Pharma Process of producing cycloalkylcarboxamido-indole compounds
JP6004307B2 (ja) * 2010-07-26 2016-10-05 富山化学工業株式会社 3−(2−(1−ベンゾチオフェン−5−イル)エトキシ)プロピオン酸の塩またはその水和物およびその製造法
JP6100174B2 (ja) 2011-03-02 2017-03-22 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH アリール酢酸誘導体及びヘテロアリール酢酸誘導体を調製する方法
EP2762225B1 (en) 2011-09-30 2018-09-12 Mitsubishi Chemical Corporation Polymerizable inorganic particle-dispersing agent, inorganic/organic composite particles containing said polymerizable inorganic particle-dispersing agent, and inorganic/organic resin composite
US9872914B2 (en) 2012-02-22 2018-01-23 Toyama Chemical Co., Ltd. Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
AU2013290444B2 (en) 2012-07-16 2018-04-26 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
EP3100725B1 (en) 2014-01-31 2020-05-06 FUJIFILM Toyama Chemical Co., Ltd. Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof
PL3925607T3 (pl) 2014-04-15 2023-10-30 Vertex Pharmaceuticals Incorporated Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
CN109526218B (zh) 2016-03-31 2021-07-06 富士胶片富山化学株式会社 5-溴甲基-1-苯并噻吩的制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA844616B (en) 1983-06-20 1986-02-26 Merck & Co Inc 2-sulfamoylbenzo(b)thiophene derivatives for the treatment of elevated intraocular pressure
NZ208444A (en) 1983-06-20 1987-08-31 Merck & Co Inc 2-thiophene derivatives and pharmaceutical compositions
US4668697A (en) * 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
CH673100A5 (pt) 1987-08-10 1990-02-15 Josef Paul Huser
JPH04182463A (ja) 1990-11-17 1992-06-30 Sumitomo Seika Chem Co Ltd ハロゲノチオフェノール類およびその誘導体の製造方法
JPH05140086A (ja) 1991-09-26 1993-06-08 Sumitomo Seika Chem Co Ltd ハロゲノチオフエノールの製造方法および精製方法
JPH05178816A (ja) 1991-12-28 1993-07-20 Sumitomo Seika Chem Co Ltd ハロゲノチオフェノールの製造方法
JP2641363B2 (ja) 1992-04-22 1997-08-13 三共株式会社 新規なフェネチルアルコール及びその製法
GB9404775D0 (en) 1994-03-11 1994-04-27 Payne P P Ltd Improvements in or relating to article tagging
JPH08143533A (ja) 1994-11-24 1996-06-04 Sumitomo Seika Chem Co Ltd ハロチオフェノール類の製造方法
JPH1043967A (ja) 1996-08-06 1998-02-17 Calsonic Corp カシメ装置
JP4245668B2 (ja) 1997-03-31 2009-03-25 富山化学工業株式会社 2−(ベンゾ〔b〕チオフェン−5−イル)−2−ヒドロキシ酢酸誘導体もしくはその光学活性体またはそれらの塩の製造法
GB9706574D0 (en) 1997-04-01 1997-05-21 Zeneca Ltd Cyano substituted cycloalkanes
JPH1112238A (ja) 1997-06-23 1999-01-19 Kao Corp 1−(β−ヒドロキシエチル)−2,5−ジアミノベンゼン又はその塩の製造法
JPH1143455A (ja) 1997-07-25 1999-02-16 Mitsubishi Chem Corp ハロゲン化アルコールの製造方法
WO1999031056A1 (fr) * 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant
EP0993105B1 (en) 1998-10-07 2003-01-08 STMicroelectronics S.r.l. Control of power transfer in a flyback converter by modulating the off-phase in function of the load
JP4182463B2 (ja) 2000-07-19 2008-11-19 富士電機デバイステクノロジー株式会社 磁気ディスク評価装置およびその方法
WO2002100850A1 (fr) 2001-06-08 2002-12-19 Kuraray Co., Ltd. Procedes de preparation de composes heterocycliques
KR100956990B1 (ko) * 2001-10-19 2010-05-11 토야마 케미칼 컴퍼니 리미티드 알킬에테르유도체 또는 그 염
MXPA05011125A (es) * 2003-04-17 2005-12-14 Toyama Chemical Co Ltd Remedio preventivo para enfermedades del nervio retiniano que contienen derivados de eter de alquilo o sales de los mismos.
JP2005012291A (ja) 2003-06-17 2005-01-13 National Institute Of Information & Communication Technology Tv会議用モバイル動画通信端末
US20050032873A1 (en) 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
WO2005019200A2 (en) 2003-08-14 2005-03-03 Icos Corporation Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
ES2398934T3 (es) * 2005-03-28 2013-03-22 Toyama Chemical Co., Ltd. Proceso de la producción de1-(3-(2-(1-benzotiofen-5-il)etoxi)propil)acetidin-ol o sales del mismo
PL2011796T3 (pl) * 2006-04-26 2015-03-31 Toyama Chemical Co Ltd Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól

Also Published As

Publication number Publication date
PT2210884E (pt) 2012-04-10
CA2600381A1 (en) 2006-10-05
JPWO2006104088A1 (ja) 2008-09-04
US7951963B2 (en) 2011-05-31
EP2248809A1 (en) 2010-11-10
PL2348022T3 (pl) 2013-06-28
KR101283930B1 (ko) 2013-07-16
NO340071B1 (no) 2017-03-06
BRPI0609496C8 (pt) 2021-05-25
IL214245A0 (en) 2011-08-31
US8273902B2 (en) 2012-09-25
CY1113571T1 (el) 2016-06-22
CN101151257B (zh) 2012-07-18
EP2248809B1 (en) 2012-05-09
NO20161418A1 (no) 2007-10-25
SI2348022T1 (sl) 2013-05-31
KR20130010090A (ko) 2013-01-25
EP2348022A1 (en) 2011-07-27
IL186044A (en) 2013-12-31
BRPI0609496C1 (pt) 2021-05-11
SI2248809T1 (sl) 2012-09-28
KR20080008334A (ko) 2008-01-23
ZA200708262B (en) 2009-01-28
ATE557020T1 (de) 2012-05-15
EP2348022B1 (en) 2013-01-09
SG155251A1 (en) 2009-09-30
KR101337382B1 (ko) 2013-12-06
AU2006229271A1 (en) 2006-10-05
EP1864978A1 (en) 2007-12-12
JP5031554B2 (ja) 2012-09-19
CA2600381C (en) 2013-11-12
NZ561672A (en) 2010-04-30
WO2006104088A1 (ja) 2006-10-05
DK2248809T3 (da) 2012-06-18
NZ583580A (en) 2010-10-29
BRPI0609496A2 (pt) 2011-10-18
NO20161419A1 (no) 2016-06-07
EP2210884A3 (en) 2010-09-22
PL2210884T3 (pl) 2012-07-31
NO340420B1 (no) 2017-04-18
ES2398934T3 (es) 2013-03-22
PL2248809T3 (pl) 2012-10-31
EP1864978A4 (en) 2009-07-01
US20110098484A1 (en) 2011-04-28
CN101151257A (zh) 2008-03-26
IL214245A (en) 2014-12-31
CA2799659C (en) 2014-12-02
ATE546443T1 (de) 2012-03-15
CY1112885T1 (el) 2016-04-13
DK2210884T3 (da) 2012-03-26
IL186044A0 (en) 2008-02-09
EP2210884B1 (en) 2012-02-22
MX2007011938A (es) 2008-03-14
SI2210884T1 (sl) 2012-06-29
AU2006229271B2 (en) 2012-02-09
ES2380443T3 (es) 2012-05-11
CA2799659A1 (en) 2006-10-05
PT2248809E (pt) 2012-07-02
EP2210884A2 (en) 2010-07-28
ES2384312T3 (es) 2012-07-03
BRPI0609496B1 (pt) 2020-11-24
CY1112956T1 (el) 2016-04-13
US20090069576A1 (en) 2009-03-12
NO340366B1 (no) 2017-04-10
NO20074618L (no) 2007-10-25

Similar Documents

Publication Publication Date Title
IL214245A0 (en) Process for production of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salts thereof
HK1132017A1 (en) Process for producing shaped refractory metal bodies
SG132645A1 (en) Process for the production of polyols based on natural oils
ZA200804556B (en) Process for producing ethylene
PL2088218T3 (pl) Blacha stalowa gruba o wysokim module Younga i sposób jej wytwarzania
MY147436A (en) Process for the synthesis of 5-(methyl-1h-imidazol-1-yl)-3-(trifluoromethyl-benzeneamine
UA103350C2 (en) Container
WO2006062673A3 (en) Processes for separating metals from metal salts
UA96971C2 (ru) Способ получения фторметилзамещенных гетероциклических соединений
IL175390A0 (en) Parocess for the preparation of telmisartan
EP1900720A4 (en) PROCESS FOR PRODUCING SUBSTITUTED CYCLOPENTANONE
EP1992613A4 (en) PROCESS FOR PRODUCTION OF 3,4-DISUBSTITUTED PYRROLIDINE DERIVATIVE AND INTERMEDIATE PRODUCTION METHOD
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
SG136920A1 (en) Process for producing methionine
EP1950319A4 (en) METHOD FOR PRODUCING A HYDROGEN STORAGE ALLOY
SI3284458T1 (sl) Postopek izdelave pastil, ki vsebujejo nesteroidno protivnetno zdravilo
ZA201006792B (en) Process for the synthesis of ethynylcylopropane
EP1849794A4 (en) PROCESS FOR THE SYNTHESIS OF A 1,2-TRANS-GLYCOSIDE DERIVATIVE
TW200740811A (en) Process for producing benzylamine derivatives
UA85383C2 (ru) Способ получения меркаптоорганил(алкоксисиланов)
UA29160U (ru) Устройство для изготовления штапельного волокна из горных пород
TW200745060A (en) Novel process
HU0501156D0 (en) Process for the production of 15-alpha-hydroxylevodion by bioconversion
TW200600548A (en) Novel oxonol compound and process for producing the compound